Catherine C Park

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
    Catherine Huang
    Lester and Sue Smith Breast Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77054, USA
    Breast Cancer Res 13:R84. 2011
  2. ncbi American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy
    Catherine C Park
    Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1600 Divisadero St, H1031, San Francisco, CA 94143 1708, USA
    Int J Radiat Oncol Biol Phys 76:963-72. 2010
  3. ncbi Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI
    Nima Nabavizadeh
    Department of Radiation Oncology, University of California, San Francisco Comprehensive Cancer Center, 1600 Divisadero Street H1031, San Francisco, CA 94143 1708, USA
    Integr Biol (Camb) 3:490-6. 2011
  4. ncbi Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo
    Catherine C Park
    Departments of Radiation Oncology and Pathology, University of California San Francisco Mt Zion Cancer Center, 1600 Divisadero Street, San Francisco, CA 94143 1708, USA
    Cancer Res 66:1526-35. 2006
  5. ncbi Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts
    Catherine C Park
    Department of Radiation Oncology, University of California Comprehensive Cancer Center, San Francisco, CA 94143 1708, USA
    Cancer Res 68:4398-405. 2008
  6. ncbi High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer
    Catherine C Park
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 73:75-9. 2009

Research Grants

  1. Manipulating b1 integrin to enhance radiation therapy for breast cancer
    Catherine Park; Fiscal Year: 2009
  2. Manipulating b1 integrin to enhance radiation therapy for breast cancer
    Catherine C Park; Fiscal Year: 2010

Collaborators

Detail Information

Publications6

  1. ncbi β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
    Catherine Huang
    Lester and Sue Smith Breast Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77054, USA
    Breast Cancer Res 13:R84. 2011
    ..The β1 integrin resides on the membrane of the breast cancer cell, activating several elements of breast tumor progression including proliferation and survival...
  2. ncbi American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy
    Catherine C Park
    Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1600 Divisadero St, H1031, San Francisco, CA 94143 1708, USA
    Int J Radiat Oncol Biol Phys 76:963-72. 2010
    ..The full Emerging Technology Committee report is available on the American Society for Therapeutic Radiology and Oncology Web site...
  3. ncbi Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI
    Nima Nabavizadeh
    Department of Radiation Oncology, University of California, San Francisco Comprehensive Cancer Center, 1600 Divisadero Street H1031, San Francisco, CA 94143 1708, USA
    Integr Biol (Camb) 3:490-6. 2011
    ..Identification of a cancer-associated stroma may be further developed to help guide local therapy to reduce recurrence and morbidity in breast cancer patients...
  4. ncbi Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo
    Catherine C Park
    Departments of Radiation Oncology and Pathology, University of California San Francisco Mt Zion Cancer Center, 1600 Divisadero Street, San Francisco, CA 94143 1708, USA
    Cancer Res 66:1526-35. 2006
    ..Our findings indicate that beta(1) integrin is a promising therapeutic target, and that the three-dimensional lrECM culture assay can be used to effectively distinguish malignant and normal tissue response to therapy...
  5. ncbi Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts
    Catherine C Park
    Department of Radiation Oncology, University of California Comprehensive Cancer Center, San Francisco, CA 94143 1708, USA
    Cancer Res 68:4398-405. 2008
    ....
  6. ncbi High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer
    Catherine C Park
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 73:75-9. 2009
    ..We hypothesized that the MBD might be a predictor of LRR after BCS and RT for invasive breast cancer...

Research Grants3

  1. Manipulating b1 integrin to enhance radiation therapy for breast cancer
    Catherine Park; Fiscal Year: 2009
    ....
  2. Manipulating b1 integrin to enhance radiation therapy for breast cancer
    Catherine C Park; Fiscal Year: 2010
    ....